Navigation Links
'Eggsploitation' Exaggerates Egg Donor Risks, Says Agency
Date:11/16/2010

CHICAGO, Nov. 16, 2010 /PRNewswire/ -- A controversial new documentary called "Eggsploitation" condemns the fertility industry for taking advantage of young women who risk their health in donating their eggs. But industry leaders say the film exaggerates the exceptions.

Mary Ellen McLaughlin, a nurse and partner with Chicago-based Alternative Reproductive Resources (ARR), points out that egg retrieval is a medical procedure, and "any such procedure entails some risk."

"Donors need to be prepared for all possible complications," she says. "And it's in our best interests – both agencies like ours as well as the medical clinics – to prepare them. The reality is that in the 15 years I've been working with egg donors, less than 1 percent has experienced any complications."

The film follows three egg donors who experienced rare complications, such as a stroke, cancer (not proven to be related to egg retrieval) and ovarian hyper-stimulation. The latter is one of the most common complications, caused by fertility medications. Another is ovarian torsion, when the ovary is rotated due to physical activity after the procedure.

Kerry was a 22-year-old college student when she donated her eggs in 2008. After her donation, she felt tired and bloated. She reviewed a pamphlet the fertility center had given her listing signs of complications and immediately contacted the on-call nurse. She was, in fact, experiencing ovarian hyper-stimulation, was treated immediately and has had no problems.

Many egg donors are, like Kerry, young college students who need to be educated on the potential health risks associated with egg donation. Says McLaughlin: "Their health is our first priority, but they also need to pay attention to their bodies and become their own advocate."  

Kerry agrees, "I paid attention to what the doctors were saying and my body. I never felt uncomfortable calling with questions or concerns."  

Contrary to the impression left by "Eggsploitation" and the media, "These women are not commodities," says McLaughlin. "They are people who need to be treated like patients, which is how ethical agencies regard them."

ARR matches egg donors and gestational surrogates with intended parents. Founded in 1992, it was the first such agency in Chicago and one of the first in the nation. Further information is available www.arr1.com, 773.327.7315.

Media contact: Robyn Velasquez, Hodge Media Strategies, 773.860.7058 or robynvelasquez@hotmail.com


'/>"/>
SOURCE Alternative Reproductive Resources
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. "Put Down the BBQ Ribs, We've Found You a Donor Heart," Nurse Tells Patient : Ohio Father near Death Gets Second Chance at Life with CardioWest™ temporary Total Artificial Heart
2. Dont Wait - Do It Now!(TM) Become an Organ and Tissue Donor
3. CryoLife, Inc. Receives Tissue From 100,000th Donor, Marking Industry Milestone
4. Agencies Unite to Launch Donor Network Alliance: First-Ever Web-Based Collective of Egg Donor Candidates
5. First-Ever Egg Donor Web Portal Becomes One of The Largest Resources for Aspiring Parents in the U.S.
6. Progenika Biopharma Grants Grifols World-Wide Distribution Rights for the BLOODCHIP® Genotyping Test for Blood Donors
7. Concentric Named Professional Agency of Record for Discovery Labs SURFAXIN(R)
8. Octapharma USA Retains Yankee Public Relations as its Agency of Record
9. Elseviers PharmaPendium(TM) Adds European Medicines Agency (EMEA) Documents
10. Fertility Agency Sweetens Incentives to Gestational Surrogates; Finds Interest Up
11. SRA Awarded $56 Million Contract by Pentagon Force Protection Agency
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2016)... ... May 20, 2016 , ... Korean researchers say Manumycin A triggers apoptosis, ... new way to treat the disease. Surviving Mesothelioma has just posted an article on ... several Korean institutions based their mesothelioma study on the fact the Manumycin A, a ...
(Date:5/19/2016)... 2016 There is no saying ... the relentless pressures in pricing and lack in consumer ... circle though - numerous opportunities are up for grabs ... ActiveWallSt.com,s presents four names in this sector: Portola Pharmaceuticals ... (NASDAQ: VTAE ), Anthera Pharmaceuticals Inc. (NASDAQ: ...
(Date:5/18/2016)... Calif. (PRWEB) , ... May 18, 2016 , ... ... awarded the Luis Villalobos Award to Cognition Therapeutics at the annual ACA Summit last ... company that is financed by one of ACA’s member angel groups. It is the ...
(Date:5/18/2016)... Washington, PA (PRWEB) , ... May 18, 2016 ... ... at least 1,200 hospitalizations are a direct result of asthma complications.* Costing more ... challenge across the country. , “For too many, the suffering ...
Breaking Biology Technology:
(Date:3/14/2016)... http://www.apimages.com ) - ... - Renvoi : image disponible via AP Images ( ... --> DERMALOG, le leader de l,innovation ... d,empreintes digitales pour l,enregistrement des réfugiés en Allemagne. ... produire des cartes d,identité aux réfugiés. DERMALOG dévoilera ...
(Date:3/10/2016)... March 10, 2016   Unisys Corporation (NYSE: ... Protection (CBP) is testing its biometric identity solution at ... to help identify certain non-U.S. citizens leaving the ... test, designed to help determine the efficiency and accuracy of ... February and will run until May 2016. --> ...
(Date:3/8/2016)... 2016   Valencell , the leading innovator ... has secured $11M in Series D financing. The ... venture fund being launched by UAE-based financial services ... investors TDF Ventures and WSJ Joshua Fund. Valencell ... triple-digit growth and accelerate its pioneering innovation in ...
Breaking Biology News(10 mins):